AWAlexander Gregory Weil

Alexander Gregory Weil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander Gregory Weil has a total of 593 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pediatric Neurogenic Stunned Myocardium: A Systematic Review and Pooled Individual-Level Analysis

    by Cédérick Montplaisir, Sudarsan Packirisamy, Nick Lee, Farbod Niazi, Aline Han, Catherine Korman, Nicolas Phaneuf-Garand, Tristan Brunette-Clément, Kenza S. Lahlou, Xavier Carmona, et al.

    Background Neurogenic stunned myocardium (NSM) is a reversible cardiac dysfunction after acute neurological injury that is well described in adults but poorly characterized in children. Objective The purpose of this study was to characterize pediatric NSM and identify factors associated with neurological outcome using individual patient data (IPD). Methods A systematic review and pooled individual-level analysis were conducted according to Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines. PubMed, Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched from inception to November 2025 for studies reporting patients ≤ 18 years with NSM and available outcome data. Demographic, neurological, and cardiac variables were extracted. Functional outcomes were assessed using the modified Rankin Scale (mRS). Results A total of 29 studies comprising 38 patients were included (mean age 7.7 years). The mean time to NSM onset was 60.8 h after neurological injury. Ventricular dysfunction occurred in 94.7%, commonly basal hypokinesis. Favorable outcome (mRS 0–2) occurred in 71.1%, while cardiac arrest occurred in 26.3% and mortality in 23.7%. Subarachnoid hemorrhage was associated with a worse outcome, whereas absence of pupil abnormalities and preserved reflexes were associated with a favorable outcome. Conclusions Pediatric NSM is usually reversible with favorable neurological outcomes but remains associated with significant morbidity and mortality. Early recognition and multidisciplinary management may improve outcomes. Larger prospective studies are needed to refine prognostic stratification.

  • Open Access

    Utility and limitations of cortico-cortical evoked potentials in pediatric resective epilepsy surgery: illustrative case

    by Sudarsan Packirisamy, Cederick Montplaisir, Tawfik Elsherbini, Kenza Sophie Lahlou, Dominic Venne, Lauren Stamm, Phillippe Major, Harrison J. Westwick, Michel W. Bojanowski, Aristides Hadjinicolaou, et al.

    BACKGROUND: The authors present the case of a 15-year-old male who underwent resection of a left parieto-occipital long-term epilepsy-associated tumor (LEAT) near the language and visual tracts. Tractography-guided dorsal language stream cortico-cortical evoked potentials (CCEPs) and visual evoked potentials (VEPs) were used intraoperatively under general anesthesia to minimize postoperative deficits. This case report describes the utility and limitations of CCEPs, VEPs, and tractography in pediatric resective epilepsy surgery. OBSERVATIONS: During resection, CCEP N1 amplitude and latency remained stable; N2 latency was prolonged by 23% (from 11.3 to 14.0 msec). VEP P100 amplitude decreased transiently by approximately 80% intraoperatively and recovered to approximately 20% below baseline at closure. Postoperative MRI showed a subcortical ischemic infarct in the occipital periventricular white matter involving the inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, and optic radiations. Postoperatively, the patient exhibited dysphasia and right homonymous hemianopia. The patient remained seizure free with improved speech at the 18-month follow-up. LESSONS: Intraoperative CCEPs, VEPs, and pre- and postoperative tractography have their uses and limitations in monitoring and assessing the integrity of language/visual white matter pathways. This case highlights underrecognized perforator-related subcortical infarction after LEAT resection and suggests a possible relationship between subcortical stroke and N2 latency changes that warrants further study. https://thejns.org/doi/10.3171/CASE25915

  • Surgical revascularization versus nonsurgical management in children with symptomatic moyamoya arteriopathy: a North American multicenter cohort study

    by Lior M. Elkaim, Jia-Shu Chen, Isaac Josh Abecassis, Alissa Sigal, George M. Ibrahim, Aria Fallah, Dominic Venne, Catherine Amlie-Lefond, Aristides Hadjinicolaou, Roland Jabre, et al.

    OBJECTIVE: Moyamoya arteriopathy is a leading cause of cerebral ischemia in children. In pediatric patients with symptomatic or progressive moyamoya disease, surgical revascularization is the mainstay of treatment; however, there is limited comparative evidence demonstrating an advantage of surgical revascularization over nonsurgical management in North American cohorts. The authors aimed to determine whether surgery reduces the risk of subsequent ischemic events in North American children with symptomatic ischemic moyamoya arteriopathy compared to nonsurgical management alone. METHODS: Patients treated conservatively at the Sainte-Justine University Hospital Center in Montréal, Canada, were compared to patients treated surgically through indirect revascularization, predominantly performed at the Seattle Children’s Hospital. Data were acquired via retrospective review of patients treated at both institutions. Time to event analysis via multivariable Cox regression for postoperative ipsilateral ischemic stroke or transient ischemic attack (TIA) recurrence was performed. RESULTS: Forty-nine patients with a median (IQR) age of 6.0 (3.0–9.0) years were included. Twenty-four patients (49.0%) were treated nonsurgically, while 25 patients (51.0%) were treated surgically. Among the 42 patients with subtype data available, 15 (35.7%) had moyamoya disease and 27 (64.3%) had moyamoya syndrome. On Kaplan-Meier analysis, patients who underwent nonsurgical management had 12-, 24-, and 60-month recurrence-free rates from an ipsilateral ischemic event of 52.8%, 52.8%, and 31.7%, respectively. In contrast, patients who underwent surgical management had 12-, 24-, and 60-month recurrence-free rates from an ipsilateral ischemic event of 87.7%, 83.0%, and 83.0%, respectively. In the entire cohort, surgical intervention (HR 0.15, 95% CI 0.04–0.51) and White race (HR 0.18, 95% CI 0.06–0.56) were both independently associated with longer time to ipsilateral ischemic event recurrence. CONCLUSIONS: Pediatric patients with symptomatic ischemic moyamoya arteriopathy treated nonsurgically had worse outcomes compared with those managed surgically. These findings support pursuing surgical revascularization therapy in North American children and youth with symptomatic ischemic moyamoya arteriopathy.


  • Open Access

    Pediatric Neurogenic Stunned Myocardium: A Systematic Review and Individual Patient Data Analysis

    by Cédérick Montplaisir, Sudarsan Packirisamy, Nick Lee, Farbod Niazi, Aline Han, Catherine Korman, Nicolas Phaneuf-Garand, Tristan Brunette-Clément, Kenza Sophie Lahlou, Xavier Carmona, et al.

    Background Neurogenic stunned myocardium (NSM) is a reversible cardiac dysfunction after acute neurological injury that is well described in adults but poorly characterized in children. Objective To characterize pediatric NSM and identify factors associated with neurological outcome using individual patient data (IPD). Methods A systematic review and IPD meta-analysis were conducted according to MOOSE guidelines. PubMed, Web of Science, and CINAHL were searched from inception to November 2025 for studies reporting patients ≤ 18 years with NSM and available outcome data. Demographic, neurological, and cardiac variables were extracted. Functional outcome was assessed using the modified Rankin Scale (mRS). Results Twenty-nine studies comprising 38 patients were included (mean age 7.7 years). The mean time to NSM onset was 60.8 hours after neurological injury. Ventricular dysfunction occurred in 94.7%, commonly basal hypokinesis. Favorable outcome (mRS 0–2) occurred in 71.1%, while cardiac arrest occurred in 26.3% and mortality in 23.7%. Subarachnoid hemorrhage was associated with worse outcome, whereas absence of pupil abnormalities and preserved reflexes were associated with favorable outcome. Conclusions Pediatric NSM is usually reversible with favorable neurological outcome but remains associated with significant morbidity and mortality. Early recognition and multidisciplinary management may improve outcomes. Larger prospective studies are needed to refine prognostic stratification.

  • Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications

    by Arjun Balachandar, Leonard H. Verhey, Karim Mithani, Hrishikesh Suresh, Elizabeth N. Kerr, Sara C. Breitbart, Fay Kisteroff, MyLoi Huynh, Alfonso Fasano, Darius Ebrahimi-Fakhari, et al.

    Deep brain stimulation (DBS) is considered off-label and investigational in pediatric populations with some exceptions. There are limited data on the relative rates of complications after DBS across different indications and targets in children. This study aimed to evaluate the safety of DBS surgery for children with movement disorders (MDs; dystonia, chorea, or tic disorders), drug-resistant epilepsy (DRE), or neurodevelopmental disorders, namely, self-injurious behavior (SIB). Data were collected both prospectively and retrospectively from children implanted with DBS through the North American multicenter Child and Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation and included demographic, clinical, operative, and postoperative variables. Complications included infection, noninfectious surgical site findings (dehiscence or seroma), hardware-related issues (disconnection or impedance change), intracranial injury, or other complications. The primary outcome was major complications, defined as any adverse event causing permanent neurologic injury or requiring surgical intervention. The secondary outcome was minor complications, defined as nonmajor complications. Generalized linear models were used to assess for any significant associations with complications. A total of 130 children and youth (mean age 12.2 ± 4.2; range 3-18) years and weighing 12.5-126.6 kg underwent DBS. The most common indication was MD (77, 59.2%), followed by DRE (47, 36.2%) and SIB (6, 4.6%). Major complications occurred in 11.5%, with a greater likelihood in MD (n = 12, 15.6%) compared with DRE (n = 2, 4.3%; odds ratio [OR] 3.55, 95% CI 2.66-4.73, p < 0.001) and significantly associated with lower weight at surgery (p < 0.001) and urgent intervention (p = 0.028). These included infection (6.2%), hardware malfunction (3.1%), and wound dehiscence (0.8%). Minor complications were also higher with MD compared with DRE (OR 1.83, 95% CI 1.16-2.89, p = 0.010) occurring in 22 participants (16.9%; 14 MD, 7 DRE, 1 SIB), including infection (6.2%), high impedance (1.5%), unrelated hydrocephalus (0.8%), perioperative worsening of symptoms (3.8%), incidental tract hemorrhage (2.3%), and noninfectious peri-electrode cystic changes (0.8%). DBS-associated complications were low across multiple pediatric indications and targets, with MD associated with higher risk of major complications. Limitations include a focus on surgical postoperative complications and not stimulation-related adverse outcomes. These findings demonstrate the safety profile of DBS in children in a large cohort.


  • Diffusion MRI Tractography to Reduce Risks of Postoperative Neurologic Deficits

    by Guido I. Guberman, Neevya Balasubramaniam, Liam Wilson, Etienne J.P. Maes, Judy Chen, Mimosa Luigi, Guillaume Theaud, Francois Rheault, Elie Bou Assi, Hitten P. Zaveri, et al.

    Despite informing on the location of functionally relevant white matter tracts, diffusion MRI tractography is not routinely used to guide neurosurgical procedures. The potential of tractography to help avoid postoperative neurologic deficits is not yet fully established. The objective of our study was to assess whether surgeries that incorporated tractography, either alone or in conjunction with other modalities, are associated with a lower risk of long-term postoperative neurologic deficits in patients undergoing resective/ablative intracranial procedures. We performed a systematic review with meta-analysis, searching through EMBASE and PubMed databases for all peer-reviewed articles published in English up until December 2024. Studies were included if they reported on intracranial resective or ablative surgeries, if they compared tractography-assisted against non-tractography-assisted approaches, and if they assessed new postoperative neurologic deficits. No restrictions were placed on the age of patients. Studies were assessed for inclusion by 2 independent reviewers, and disagreements were settled by a third. Data extraction was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, quality of studies was evaluated using the GRADE framework, and risk of bias was assessed through a modified version of the Newcastle-Ottawa Quality Assessment Scale for Cohort Studies. Data were pooled using a random-effects model with a Mantel-Haenszel method for estimating risk ratios. The primary outcome consisted in any neurologic deficits present at the last follow-up (≥3 months). Of 5,335 studies initially identified, 8 were included after all stages of review, all of which consisted of resective surgeries. A meta-analysis of 629 patients revealed a 55% risk reduction of postoperative neurologic deficits when tractography was incorporated in the neurosurgical workflow. This benefit was consistent when assessing studies where tractography was exclusively used preoperatively. Furthermore, the incorporation of tractography into intraoperative neuronavigation systems was associated with lower proportions of postoperative neurologic deficits, compared with exclusively preoperative tractography. These benefits were found to be present in several additional subgroup and sensitivity analyses. The addition of tractography is associated with a reduced risk of postoperative neurologic deficits in intracranial resective surgeries. Tractography can complement gold standard brain mapping methods such as direct electrical stimulation during awake surgeries or serve as a helpful alternative when electrical stimulation is contraindicated.


  • Open Access

    Challenges and opportunities for new intraoperative optical techniques in the surgical treatment of pituitary adenomas: a review

    by Félix Janelle, Victor Blanquez-Yeste, Trang Tran, Abdelhakim Khellaf, Romain Cayrol, Catherine Beauregard, André Lacroix, Alexander G. Weil, Philippe Lavigne, Frédéric Leblond, et al.

    SignificanceSurgery is a common intervention for patients with pituitary adenomas, particularly those experiencing endocrine symptoms or mass effect. Persistent challenges in pituitary surgery include the detection of small microadenomas, difficulty in discerning residual tumor from normal gland, and infiltrative adenomas. Although standard perioperative diagnostics include magnetic resonance imaging (MRI), computed tomography, ultrasound imaging, and neuronavigation, some centers employ intraoperative MRI, ultrasound, and fluorescence-guided endoscopy to increase the rate of gross total resection and preserve pituitary function. However, these techniques are often limited by availability, time requirements, cost, and inability to provide histological diagnosis.AimThis review addresses opportunities to optimize both the extent of resection and gland preservation in pituitary adenoma procedures. We discuss the existing constraints faced in pituitary surgery and showcase the current and emerging detection techniques employed in clinical practice, as well as their limitations. We also discuss newer probing approaches such as elastography and Raman spectroscopy.ApproachWe outline key attributes for an ideal optical tool, considering surgical theater functionality, ergonomics, and result reliability and accuracy.ResultsA case study is presented describing the recent development of a fiber-optics instrument specifically designed for endonasal applications based on clinical requirements, along with preliminary data supporting the feasibility of intraoperative implementation.ConclusionsCurrent imaging and navigation tools, although invaluable, have inherent limitations in resolution, integration, and molecular specificity. Raman spectroscopy offers a promising, label-free method for real-time tissue identification, especially when integrated into fiber-optic probes for endonasal use. As a complementary tool, it could enhance intraoperative decision-making and surgical precision. Further clinical validation is needed to support its integration into standard workflows.


  • Open Access

    What defines response to vagus nerve stimulation in children with drug‐resistant epilepsy? A prospective cohort study from the CONNECTiVOS collaboration

    by Farbod Niazi, Karim Mithani, Hrishikesh Suresh, Simeon M. Wong, Ivanna Yau, Lyndsey McRae, Thiemo F. Dinger, James T. Rutka, Ayako Ochi, Hiroshi Otsubo, et al.

    Objectives: Responsiveness to vagus nerve stimulation (VNS) in children with drug‐resistant epilepsy (DRE) is often defined based on reduction in seizure frequency, typically at the 50% threshold, with limited consideration to the effects of therapy on seizure severity and health‐related quality of life (HRQoL). In the current report, we sought to better characterize the effects of VNS beyond seizure frequency in children with DRE. Methods: Sixty‐seven children from the Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS) database, a multicenter study including children aged 0–18 who underwent VNS at eight North American centers, were included. Data were collected prospectively at baseline and 6, 12, and 24 months after VNS. Seizure outcomes were assessed using the 50% threshold, percentage change in seizure count and change on a frequency timescale, a categorical measure of seizure occurrence (e.g., daily to weekly seizures). The Seizure Severity Questionnaire and the Quality of Life in Childhood Epilepsy were also collected. Linear mixed models were constructed to study longitudinal changes in seizure severity and HRQoL. Results: Among 67 children, 55.2% experienced >50% reduction in seizures, whereas only 37.3% demonstrated reductions in seizure timescales. Notably, 17.9% experienced no reduction in timescales despite meeting the 50% threshold. Furthermore, 31.9% of children experienced a meaningful improvement in seizure severity without any reduction in seizure timescales. HRQoL improvements were driven by the reduction in timescales (mean yearly increase of 3.65; 95% confidence interval [CI]: 0.71–6.52, p = 0.023), rather than responsiveness based on the 50% threshold or percentage change in seizure counts ( p > 0.05). Reduced overall seizure severity was also independently associated with higher HRQoL after VNS ( p = 0.035). Significance: The conventional 50% responder threshold failed to capture meaningful gains in HRQoL, which aligned more closely with seizure timescales. Furthermore, nearly one‐third of children realized improvements in seizure severity without any reduction in timescales. Improvements in both seizure frequency timescales and seizure severity drive postoperative HRQoL gains.


  • Open Access

    Supplementary Figure S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions

    by Audrey-Anne Lamoureux, Michael J. Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Christof Kramm, Bram De Wilde, Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, et al.

    Supplementary Figure S2. A) Hazard ratio for progression or death according to clinical characteristics. B) Hazard ratio for death according to clinical characteristics. LGG: Low-grade glioma, HGG: High-grade glioma

  • Open Access

    Supplementary Table S4 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions

    by Audrey-Anne Lamoureux, Michael J. Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Christof Kramm, Bram De Wilde, Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, et al.

    Supplementary Table S4. Other molecular alterations reported.